CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, ...

Lineage trades at a NAV discount with recovery potential, a 6.1% yield at 64% payout, expanding scale, and catalysts from rates. Read why LINE stock is a buy.

Forbes contributors publish independent expert analyses and insights. Gary Drenik is a writer covering AI, analytics and innovation. AI rarely fails because of bad models alone. More often it fails ...

As your data evolves, you need a way to track the who, what, when, why, and how of those changes. You need a data lineage system. Databases are good at inserting, updating, querying, and deleting data ...

Lineage Logistics is a global leader in operating temperature-controlled warehouses. The sector has faced several headwinds since the REIT's initial public offering in late 2024. W.P. Carey's more ...

Cold storage warehouse operator Lineage, Inc. provided an update on some longer-term initiatives after the market closed on Monday. It also provided an expected financial contribution from the ...

Lineage enters a definitive agreement to acquire multiple cold storage warehouses with plans to enter an additional agreement to build two fully automated warehouses in the U.S. NOVI, Mich.--(BUSINESS ...

Lineage (LINE), the world’s largest cold storage operator, is trading over 50% below recent highs but remains a dominant industry force. LINE is well-positioned for long-term growth and industry ...

Methods for tracing lineage can be divided into two groups. Prospective methods trace lineage forwards from the application of an experimentally delivered marker, and retrospective methods trace ...